Skip to main content

Refine your search

SARS-COV-2 vaccination development in a lab

Tuija Keinonen appointed as CEO of Rokote Laboratories Finland

The Finnish coronavirus vaccine developer Rokote Laboratories Finland Ltd. has appointed Tuija Keinonen, Doctor of Science (Pharmacy), as the company's new CEO.

Keinonen has a long career in the pharmaceutical industry, especially as service business CEO, most recently at Medfiles Ltd. She also serves in an advisory capacity and as a board member in a number of Finnish biosector companies, such as TILT Biotherapeutics Ltd., which develops cancer therapy.

It is great to be involved in building a common and safer future, and to launch vaccine production also here in Finland.

Tuija Keinonen

CEO, Rokote Laboratories Finland Ltd.

Tuija Keinonen